Verdezyne Signs Agreement With Major European Chemicals Distributor Will & Co

11-Jun-2015 - USA
Verdezyne, Inc., a privately-held industrial biotechnology company focused on producing renewable chemicals, has reached an agreement with Will & Co for distribution of Verdezyne’s first commercial product. The exclusive agreement is for sales and distribution of BIOLON™ DDDA (biobased dodecanedioic acid or “DC12”) in Europe. BIOLON™ DDDA will be produced at Verdezyne’s commercial-scale plant in Malaysia. The agreement secures off-take for over 25% of the expected plant capacity.
“This agreement with Will & Co is an important milestone for us because it reflects the strong demand for renewable chemicals and the demonstrated high quality of our product,” said E. William Radany, Ph.D., President and CEO of Verdezyne. “With a focus on serving customers, Will & Co is the perfect partner for us and we are proud to be associated with them. Having forged this mutually beneficial distribution partnership for a significant portion of our production capacity, we are even more excited to start producing BIOLON™ DDDA as soon as possible.”
Verdezyne’s plant, expected to open in 2017, is anticipated to have the capacity to produce over 10,000 metric tons of diacids annually, including BIOLON™ DDDA, drawing on Malaysia’s diverse and abundant base of plant-derived feedstocks.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances